PH
Philipp Hofer
Research areas: Medicine · Infectious Diseases · Genetic Associations and Epidemiology · Genetic factors in colorectal cancer · SARS-CoV-2 and COVID-19 Research
0000-0003-2550-6019
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (32)
- Time-resolved immune dynamics in rheumatoid arthritis under methotrexate therapy Save
- Utilization Patterns of Hospital Biobank Samples: Time to First Use and Material-Specific Demand Save
- Time-resolved immune dynamics in rheumatoid arthritis under Methotrexate therapy Save
- Time-resolved immune dynamics in rheumatoid arthritis under methotrexate therapy Save
- Evaluation of the "Burgenland PREvention trial of colorectal cancer Disease with ImmunologiCal Testing" (B-PREDICT)-a population-based colorectal cancer screening program. Save
- Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases. Save
- Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial. Save
- Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls. Save
- Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study. Save
- Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial. Save
- Delays during PBMC isolation have a moderate effect on yield, but severly compromise cell viability Save
- Delays during PBMC isolation have a moderate effect on yield, but severly compromise cell viability. Save
- Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomized controlled trial Save
- SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity. Save
- Personalized medicine in Austria: expectations and limitations. Save
- Quality management at the national biobanking level - establishing a culture of mutual trust and support: the BBMRI.at example. Save
- Association analyses identify 31 new risk loci for colorectal cancer susceptibility. Save
- Novel Common Genetic Susceptibility Loci for Colorectal Cancer. Save
- Plasma metabolites associated with colorectal cancer: A discovery-replication strategy. Save
- Genome-wide association analysis of diverticular disease points towards neuromuscular, connective tissue and epithelial pathomechanisms. Save